Need help finding what you are looking for?
Contact Us
PUBLISHER: BCC Research | PRODUCT CODE: 1235048
PUBLISHER: BCC Research | PRODUCT CODE: 1235048
Global Spatial Genomics and Transcriptomics Market
PUBLISHED:
PAGES: 157 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
Highlights:
The global market for spatial genomics and transcriptomics is estimated to increase from $1.5 billion in 2022 to reach $2.5 billion by 2027, at a compound annual growth rate (CAGR) of 10.8% from 2022 through 2027.
Spatial genomics market is estimated to increase from $1.1 billion in 2022 to reach $1.8 billion by 2027, at a CAGR of 10.8% from 2022 through 2027.
Spatial transcriptomics market is estimated to increase from $425.1million in 2022 to reach $707.5 million by 2027, at a CAGR of 10.7% from 2022 through 2027.
Report Scope:
This report incorporates an in-depth analysis of the spatial genomics and transcriptomics market, including market estimations and trends through 2021. Major players, competitive intelligence, innovative technologies, market dynamics and regional opportunities are discussed in detail. The report examines recent developments and product portfolios of major players. The product analysis focuses on recent technological trends in various regions, such as the U.S., Europe, and Japan. The report presents a market analysis and estimates the compound annual growth rate (CAGR) for spatial genomics and transcriptomics technologies.
The scope of the report covers only those spatial genomics and transcriptomics technologies that generate the most global revenue. Spatial genomics and transcriptomics are similar to spatial biology.
This report segments the global market by the geographic regions of North America, Europe, Asia-Pacific and the Rest of the World. For market estimates, data are provided for 2021 as the base year and forecast through the end of 2027.
Report Includes:
- 34 data tables and 30 additional tables
- An overview of the global spatial genomics and transcriptomics market
- Analyses of global market trends with data from 2020-2022, and projections of compound annual growth rates (CAGRs) through 2027
- Estimation of the market size and highlights of the market potential by technology, end user, and application
- Detailed description of fluorescence In situ hybridization and microscopy RNA imaging and discussion on their application in the genomics industry
- Assessment of the current market size and forecast of market development in the coming five years, and insight into the value chain analysis, and factors driving and restraining the growth
- Information on recent mergers, acquisitions, collaborations, agreements, partnerships, product launches, and expansions in the global spatial genomics and transcriptomics market
- Identification of the major stakeholders and analysis of the competitive landscape based on recent developments, financial performance, and segmental revenues
- Company profiles of the leading global players, including Advanced Cell Diagnostics Inc., Bruker, Illumina, Standard BioTools Inc., Vizgen and Lunaphore
Product Code: BIO239A
Table of Contents
Chapter 1 Introduction
- 1.1 Study Goals and Objectives
- 1.2 Reasons for Doing this Study
- 1.3 Scope of Report
- 1.4 Information Sources
- 1.5 Methodology
- 1.6 Geographic Breakdown
- 1.7 Analyst's Credentials
- 1.8 BCC Custom Research
- 1.9 Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market Overview
- 3.1 Spatial Genomics and Transcriptomics
- 3.1.1 Spatial Genomics
- 3.1.2 Spatial Transcriptomics
- 3.2 Spatial Transcriptomics Technologies
- 3.2.1 Fusion of Multiple Technologies
- 3.2.2 Spatial Genomics and Transcriptomics Provides Balance
- 3.3 Understanding Spatial Biology
- 3.4 Importance of Spatial Biology
- 3.5 Spatial Sequencing
- 3.6 Spatial Biology of Cancer Evolution
- 3.7 Innovation in Medical and Healthcare Products
- 3.8 Current Trends
- 3.8.1 Enhanced Cybersecurity
- 3.8.2 Internet of Medical Things
- 3.8.3 Medical Robots
- 3.8.4 Three-Dimensionally Printed Objects
- 3.8.5 Device Connectivity
- 3.8.6 Implications for Health Systems
- 3.9 Regulations and Legislation
- 3.9.1 Europe
- 3.9.2 U.S.
- 3.9.3 Japan
Chapter 4 Market Dynamics
- 4.1 Drivers
- 4.1.1 New Discoveries in Biological Sciences
- 4.1.2 Increasing Use of Bioinformatics Analytical Software
- 4.1.3 Antibody-Based Drug Discovery and Development
- 4.1.4 Developed and Increasing Research Areas
- 4.1.5 Application-Focused Technology Platforms
- 4.1.6 Strengthen Use and Adoption of Consumables
- 4.1.7 Increase in Infectious and Chronic Diseases
- 4.1.8 Relationships among Biopharma Firms, Research Institutions and Medical Centers
- 4.2 Restraints
- 4.2.1 Labor-Intensive Technology and Products
- 4.3 Opportunities
- 4.3.1 Human Genome Project Development
- 4.3.2 Coming Revolution of Precision Medicine
- 4.4 Strategies
- 4.4.1 Trends
Chapter 5 Impact of the COVID-19 Pandemic
- 5.1 Impact of COVID-19 on Pharmaceutical and Biotech Industries
- 5.2 Short-Term Impact
- 5.2.1 Change in Demand
- 5.2.2 Shift of Communication and Promotions to Remote Interactions
- 5.2.3 Changes in R&D
- 5.3 Long-Term Impact
- 5.3.1 Delayed Approvals for Non-COVID-Related Pharmaceutical and Biotech Products
- 5.3.2 Self-Sufficiency in the Pharma and Biotech Industries
- 5.3.3 Pharmaceutical Industry Growth Slowdown
- 5.3.4 Changes in Consumption Trends in Health-Related Products
- 5.3.5 Potential Impact of COVID-19 on Genomic Study
Chapter 6 Business Model and Innovation
- 6.1 Business Model Innovation
Chapter 7 Global Spatial Genomics and Transcriptomics: Technology Market
- 7.1 Overview
- 7.2 Spatial Genomics
- 7.2.1 Market Outlook
- 7.3 Spatial Transcriptomics
- 7.3.1 Market Outlook
Chapter 8 Global Spatial Genomics and Transcriptomics Market by Product
- 8.1 Overview
- 8.2 Market for Spatial Genomics and Transcriptomics, by Product
- 8.3 Market Outlook
- 8.3.1 Consumables
- 8.3.2 Instruments
- 8.3.3 Software
Chapter 9 Global Spatial Genomics and Transcriptomics Market by Application
- 9.1 Overview
- 9.2 Spatial Genomics and Transcriptomics Market by Application
- 9.3 Market Outlook
- 9.3.1 Clinical and Translational Research
- 9.3.2 Drug Discovery and Development
Chapter 10 Global Spatial Genomics and Transcriptomics Market by End User
- 10.1 Overview
- 10.2 Market for Spatial Genomics and Transcriptomics by End User
- 10.3 Market Outlook
- 10.3.1 Academic and Research Institutes
- 10.3.2 Contract Research Organizations
- 10.3.3 Pharmaceutical and Biotechnology
Chapter 11 Global Spatial Genomics and Transcriptomics Market by Region
- 11.1 North America
- 11.1.1 Market Outlook
- 11.2 Europe
- 11.2.1 Market Outlook
- 11.3 Asia-Pacific
- 11.3.1 Market Outlook
- 11.4 Rest of the World
- 11.4.1 Market Outlook
Chapter 12 Competitive Landscape
Chapter 13 Company Profiles
- 10X GENOMICS
- ADVANCED CELL DIAGNOSTICS INC.
- AKOYA BIOSCIENCES INC.
- BRUKER CORP.
- DOVETAIL GENOMICS (CANTATA BIO)
- ILLUMINA
- IONPATH INC.
- LUNAPHORE TECHNOLOGIES S.A.
- NANOSTRING TECHNOLOGIES
- RARECYTE INC.
- STANDARD BIOTOOLS INC.
- VIZGEN INC.
- Other Companies
Product Code: BIO239A
List of Tables
- Summary Table : Global Spatial Genomics and Transcriptomics Market, by Technology, Through 2027
- Table 1 : Differences Between Single-Cell RNA-Seq and RNA-Seq
- Table 2 : Class I and II Exempt Devices
- Table 3 : Akoya's Relationship with Universities and Organizations
- Table 4 : Global Spatial Genomics and Transcriptomics Market, by Technology, Through 2027
- Table 5 : Global Spatial Genomics and Transcriptomics Market, by Genomics Technology, Through 2027
- Table 6 : Global Spatial Genomics and Transcriptomics Technologies Market, by Transcriptomics, Through 2027
- Table 7 : Global Spatial Genomics and Transcriptomics Market, by Product, Through 2027
- Table 8 : Global Spatial Genomics and Transcriptomics Market, by Application, Through 2027
- Table 9 : Global Spatial Genomics and Transcriptomics Market, by End User, Through 2027
- Table 10 : North American Spatial Genomics and Transcriptomics Market, by Technology, Through 2027
- Table 11 : North American Spatial Genomics and Transcriptomics Market, by Genomics Technology, Through 2027
- Table 12 : North American Spatial Genomics and Transcriptomics Technologies Market, by Transcriptomics, Through 2027
- Table 13 : North American Spatial Genomics and Transcriptomics Market, by Product, Through 2027
- Table 14 : North American Spatial Genomics and Transcriptomics Market, by Application, Through 2027
- Table 15 : North American Spatial Genomics and Transcriptomics Market, by End User, Through 2027
- Table 16 : North American Spatial Genomics and Transcriptomics Market, by Country, Through 2027
- Table 17 : European Spatial Genomics and Transcriptomics Market, by Technology, Through 2027
- Table 18 : European Spatial Genomics and Transcriptomics Market, by Genomics Technology, Through 2027
- Table 19 : European Spatial Genomics and Transcriptomics Technologies Market, by Transcriptomics, Through 2027
- Table 20 : European Spatial Genomics and Transcriptomics Market, by Product, Through 2027
- Table 21 : European Spatial Genomics and Transcriptomics Market, by Application, Through 2027
- Table 22 : European Spatial Genomics and Transcriptomics Market, by End User, Through 2027
- Table 23 : European Spatial Genomics and Transcriptomics Market, by Country, Through 2027
- Table 24 : Asia-Pacific Spatial Genomics and Transcriptomics Market, by Technology, Through 2027
- Table 25 : Asia-Pacific Spatial Genomics and Transcriptomics Technologies Market, by Transcriptomics, Through 2027
- Table 26 : Asia-Pacific Spatial Genomics and Transcriptomics Market, by Product, Through 2027
- Table 27 : Asia-Pacific Spatial Genomics and Transcriptomics Market, by Product, Through 2027
- Table 28 : Asia-Pacific Spatial Genomics and Transcriptomics Market, by Application, Through 2027
- Table 29 : Asia-Pacific Spatial Genomics and Transcriptomics Market, by End User, Through 2027
- Table 30 : Asia-Pacific Spatial Genomics and Transcriptomics Market, by Country, Through 2027
- Table 31 : RoW Spatial Genomics and Transcriptomics Market, by Technology, Through 2027
- Table 32 : RoW Spatial Genomics and Transcriptomics Market, by Genomics Technology, Through 2027
- Table 33 : RoW Spatial Genomics and Transcriptomics Technologies Market, by Transcriptomics, Through 2027
- Table 34 : RoW Spatial Genomics and Transcriptomics Market, by Product, Through 2027
- Table 35 : RoW Spatial Genomics and Transcriptomics Market, by Application, Through 2027
- Table 36 : RoW Spatial Genomics and Transcriptomics Market, by End User, Through 2027
- Table 37 : RoW Spatial Genomics and Transcriptomics Market, by Country, Through 2027
- Table 38 : Recent Company News, 2022
- Table 39 : 10xGenomics: Product Portfolio
- Table 40 : 10xGenomics: Recent Developments, 2020-2022
- Table 41 : Advanced Cell Diagnostics Inc.: Product Portfolio
- Table 42 : Advanced Cell Diagnostics Inc.: Recent Developments, 2019-2023
- Table 43 : Akoya Biosciences Inc.: Product Portfolio
- Table 44 : Akoya Biosciences Inc.: Recent Developments, 2020-2022
- Table 45 : Bruker: Product Portfolio
- Table 46 : Bruker: Recent Developments, 2021-2023
- Table 47 : Dovetail Genomics: Product Portfolio
- Table 48 : Dovetail Genomics: Recent Developments, 2019-2022
- Table 49 : Illumina: Product Portfolio
- Table 50 : Illumina: Recent Developments, 2020-2023
- Table 51 : Ionpath Inc.: Product Portfolio
- Table 52 : Ionpath Inc.: Recent Developments, 2020-2022
- Table 53 : Lunaphore: Product Portfolio
- Table 54 : Lunaphore: Recent Developments, 2022
- Table 55 : NanoString: Product Portfolio
- Table 56 : NanoString: Recent Developments, 2020-2022
- Table 57 : RareCyte: Product Portfolio
- Table 58 : RareCyte: Recent Developments, 2021 and 2022
- Table 59 : Standard BioTools Inc.: Product Portfolio
- Table 60 : Standard BioTools Inc.: Recent Developments, 2019-2022
- Table 61 : Vizgen: Product Portfolio
- Table 62 : Vizgen: Recent Developments, 2021-2023
- Table 63 : Other Spatial Genomics and Transcriptomics Startups
List of Figures
- Summary Figure : Global Market for Spatial Genomics and Transcriptomics, by Genomics Technologies, 2019-2027
- Figure 1 : Spatial Transcriptomics Results from Fusion of Multiple Technologies
- Figure 2 : U.S. Medical Device Marketing Process
- Figure 3 : Global Projected Diabetes Incidence, Patients Age 20-79, 2010 and 2030
- Figure 4 : Global Infectious Diseases Incidence, Between 2020 and 2022
- Figure 5 : Global Infectious Diseases Outbreak, 2022
- Figure 6 : Impact of COVID-19 on the Pharmaceutical and Biotech Industries
- Figure 7 : Business Models' Five Interconnected Components
- Figure 8 : Lead Gears Drive the Business Model Shift
- Figure 9 : Global Market Shares of Spatial Genomics and Transcriptomics, by Technology, 2021
- Figure 10 : Global Market Shares of Spatial Genomics and Transcriptomics Technologies, by Genomics Technology, 2021
- Figure 11 : Global Market Shares of Spatial Genomics and Transcriptomics Technologies, by Transcriptomics, 2021
- Figure 12 : Global Market Shares of Spatial Genomics and Transcriptomics Technologies, by Product, 2021
- Figure 13 : Global Market Shares of Spatial Genomics and Transcriptomics, by Application, 2021
- Figure 14 : Growth of Multi-Omics in Different End Users
- Figure 15 : Global Market Shares of Spatial Genomics and Transcriptomics Technologies, by End User, 2021
- Figure 16 : North American Market Shares of Spatial Genomics and Transcriptomics, by Technology, 2021
- Figure 17 : North American Market Shares of Spatial Genomics and Transcriptomics Technologies, by Genomics Technology, 2021
- Figure 18 : North American Market Shares of Spatial Genomics and Transcriptomics Technologies Market, by Transcriptomics, 2021
- Figure 19 : North American Market Shares of Spatial Genomics and Transcriptomics Technologies, by Product, 2021
- Figure 20 : North American Market Shares of Spatial Genomics and Transcriptomics, by Application, 2021
- Figure 21 : North American Market Shares of Spatial Genomics and Transcriptomics Technologies, by End User, 2021
- Figure 22 : North American Market Shares of Spatial Genomics and Transcriptomics Technologies, by Country, 2021
- Figure 23 : U.S. Population Age 65 or Older, 2010-2050
- Figure 24 : European Market Shares of Spatial Genomics and Transcriptomics, by Technology, 2021
- Figure 25 : European Market Shares of Spatial Genomics and Transcriptomics Technologies, by Genomics Technologies, 2021
- Figure 26 : Figure 26 European Market Shares of Spatial Genomics and Transcriptomics Technologies Market, by Transcriptomics, 2021
- Figure 27 : European Market Shares of Spatial Genomics and Transcriptomics Technologies, by Product, 2021
- Figure 28 : European Market Shares of Spatial Genomics and Transcriptomics, by Application, 2021
- Figure 29 : European Market Shares of Spatial Genomics and Transcriptomics Technologies, by End User, 2021
- Figure 30 : European Market Shares of Spatial Genomics and Transcriptomics Technologies, by Country, 2021
- Figure 31 : Asia-Pacific Market Shares of Spatial Genomics and Transcriptomics, by Technology, 2021
- Figure 32 : Asia-Pacific Market Shares of Spatial Genomics and Transcriptomics Technologies, by Genomics Technology, 2021
- Figure 33 : Asia-Pacific Market Shares of Spatial Genomics and Transcriptomics Technologies Market, by Transcriptomics, 2021
- Figure 34 : Asia-Pacific Market Shares of Spatial Genomics and Transcriptomics Technologies, by Product, 2021
- Figure 35 : Asia-Pacific Market Shares of Spatial Genomics and Transcriptomics, by Application, 2021
- Figure 36 : Asia-Pacific Market Shares of Spatial Genomics and Transcriptomics Technologies, by End User, 2021
- Figure 37 : Asia-Pacific Market Shares of Spatial Genomics and Transcriptomics Technologies, by Country, 2021
- Figure 38 : RoW Market Shares of Spatial Genomics and Transcriptomics, by Technology, 2021
- Figure 39 : RoW Spatial Genomics and Transcriptomics Market Shares, by Genomics Technology, 2021
- Figure 40 : RoW Market Shares of Spatial Genomics and Transcriptomics Technologies, by Transcriptomics, 2021
- Figure 41 : RoW Market Shares of Spatial Genomics and Transcriptomics Technologies, by Product, 2021
- Figure 42 : RoW Market Shares of Spatial Genomics and Transcriptomics, by Application, 2021
- Figure 43 : RoW Market Shares of Spatial Genomics and Transcriptomics Technologies, by End User, 2021
- Figure 44 : RoW Market Shares of Spatial Genomics and Transcriptomics Technologies, by Country, 2021
- Figure 45 : Ranking of Spatial Genomics and Transcriptomics Companies, 2021
- Figure 46 : Ranking of Spatial Genomics and Transcriptomics Private Companies, 2021
- Figure 47 : 10xGenomics: Annual Revenue, 2019-2021
- Figure 48 : 10xGenomics: Revenue Share, by Business Segment, 2021
- Figure 49 : 10xGenomics: Revenue Share, by Region, 2021
- Figure 50 : Bio-Techne: Annual Revenue, 2020-2022
- Figure 51 : Bio-Techne: Revenue Share, by Business Segment, 2021
- Figure 52 : Akoya Biosciences Inc.: Annual Revenue, 2020 and 2021
- Figure 53 : Akoya Biosciences Inc.: Revenue Share, by Business Segment, 2021
- Figure 54 : Bruker: Annual Revenue, 2019-2021
- Figure 55 : Bruker: Revenue Share, by Business Segment, 2021
- Figure 56 : Illumina: Annual Revenue, 2019-2021
- Figure 57 : Illumina: Revenue Share, by Business Segment, 2021
- Figure 58 : NanoString: Annual Revenue, 2019-2021
- Figure 59 : NanoString: Revenue Share, by Business Segment, 2021
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.